Case–Control and Family‐Based Association Study of Specific PTPRD Variants in Restless Legs Syndrome

The exact genetic causes within each of the known restless legs syndrome (RLS) loci are still unknown. Recently, it was suggested that an intronic protein tyrosine phosphatase, receptor type δ (PTPRD) single‐nucleotide polymorphism (SNP) (reference SNP no. rs2381970) is associated with its expression, which may lead to RLS and other related phenotypes. Another study identified 3 nonsynonymous PTPRD variants in familial RLS cases: p.Q447E (a residue change from glutamine to glutamic acid at position 447), p.T781A (a residue change from threonine to alanine at position 781), and p.R995C (a residue change from arginine to cysteine at position 995).

[1]  A. Desautels,et al.  Analysis of functional GLO1 variants in the BTBD9 locus and restless legs syndrome. , 2015, Sleep medicine.

[2]  G. Uhl,et al.  Mouse Model for Protein Tyrosine Phosphatase D (PTPRD) Associations with Restless Leg Syndrome or Willis-Ekbom Disease and Addiction: Reduced Expression Alters Locomotion, Sleep Behaviors and Cocaine-Conditioned Place Preference , 2015, Molecular medicine.

[3]  Richard P Allen,et al.  Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. , 2014, Sleep medicine.

[4]  T. van Groen,et al.  Motor restlessness, sleep disturbances, thermal sensory alterations and elevated serum iron levels in Btbd9 mutant mice. , 2012, Human molecular genetics.

[5]  R. O'Hara,et al.  Epidemiology of restless legs syndrome: a synthesis of the literature. , 2012, Sleep medicine reviews.

[6]  H. Jinnah,et al.  Sleep Fragmentation and Motor Restlessness in a Drosophila Model of Restless Legs Syndrome , 2012, Current Biology.

[7]  J. Montplaisir,et al.  Restless legs syndrome‐associated MEIS1 risk variant influences iron homeostasis , 2011, Annals of neurology.

[8]  C. Gieger,et al.  Genome-Wide Association Study Identifies Novel Restless Legs Syndrome Susceptibility Loci on 2p14 and 16q12.1 , 2011, PLoS genetics.

[9]  J. Montplaisir,et al.  MEIS1 intronic risk haplotype associated with restless legs syndrome affects its mRNA and protein expression levels. , 2009, Human molecular genetics.

[10]  C. Gieger,et al.  PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome , 2008, Nature Genetics.

[11]  Lisa M. Schwartz,et al.  A genetic risk factor for periodic limb movements in sleep. , 2008, The New England journal of medicine.

[12]  Christian Gieger,et al.  Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions , 2007, Nature Genetics.

[13]  K. Berger,et al.  Epidemiology of restless legs syndrome: the current status. , 2006, Sleep medicine reviews.

[14]  N. Laird,et al.  The family based association test method: strategies for studying general genotype–phenotype associations , 2001, European Journal of Human Genetics.